•   
  •   

UK News UK reaches agreements on access to 90m doses of potential Covid-19 vaccines

13:30  14 august  2020
13:30  14 august  2020 Source:   msn.com

Livingston factory could help produce 60 million doses of vaccine

  Livingston factory could help produce 60 million doses of vaccine Business Secretary Alok Sharma will visit a plant in Livingston as it scales up production of a ‘promising’ vaccine candidate.The UK government and the drugs firm are investing in the Livingston plant, with 75 new jobs expected to be created.

The UK government has reached agreements it says will give British citizens early access to 90 m doses of two more potential Covid - 19 vaccines . A further 100 million doses of vaccine could come from one being developed by Oxford University in partnership with AstraZeneca, while a deal

We’ve secured early access to 90 million doses of promising coronavirus vaccine candidates from @BioNTech_Group , @pfizer and @valnevaSE A new NHS Covid - 19 vaccine research registry has also been established with the aim of recruiting 500,000 volunteers by October to test new vaccines

a close up of a hand: The Government has reached in-principle agreements with US biotech company Novavax and pharmaceutical business Janssen (David Cheskin/PA) © David Cheskin The Government has reached in-principle agreements with US biotech company Novavax and pharmaceutical business Janssen (David Cheskin/PA)

The Government has reached agreements it says will give British citizens early access to 90 million doses of two more potential Covid-19 vaccines.

The vaccines are being developed by US biotech company Novavax and pharmaceutical business Janssen, which is headquartered in Belgium and owned by Johnson & Johnson.

London Marathon mass race to be cancelled, elite race on

  London Marathon mass race to be cancelled, elite race on London Marathon mass race to be cancelled, elite race onLONDON (Reuters) - The mass participation London Marathon has been cancelled due to COVID-19 but an elite-only race, on a short loop on a fan-restricted circuit and featuring Eliud Kipchoge and Kenenisa Bekele, will be held on Oct. 4, sources said on Thursday.

The UK government has signed deals for a further 90 million doses of coronavirus vaccine . "Today's agreements will not only benefit people in the UK but will ensure fair and equitable access of a vaccine around the world, potentially protecting hundreds COVID - 19 : Assessing long term recovery.

It now has orders for at least 340million doses of vaccines against Covid - 19 . The UK has agreed to support Novavax in its attempts to make a coronavirus vaccine While the Government revealed a 60million dose deal on July 20, the company said it had reached agreement in principle with the UK

Under the in-principle agreements, the UK has secured 60 million doses of the Novavax vaccine, with it supporting a Phase 3 clinical trial with the National Institute for Health Research (NIHR).

Some 30 million doses have been secured from Janssen and ministers have agreed in principle to co-fund a global clinical study of its vaccine.

a screenshot of a cell phone: (PA Graphics) © Provided by PA Media (PA Graphics)

The new agreements, on top of earlier deals, mean the UK now has access to six different Covid-19 vaccine candidates in development, across four different types, representing some 340 million doses.

Despite the scale of the Government’s potential stockpile, Kate Bingham, chair of the Government’s Vaccines Taskforce, warned that it was still not known if any of the vaccines would be effective.

South Africa: health personnel devastated by Covid-19

 South Africa: health personnel devastated by Covid-19 © Provided by Le Point To understand the scale of the disaster, it is important to know that the approximately 24,000 health personnel infected by the new coronavirus since the start of the pandemic in March represent around 5% of the total number of Covid-19 cases in South Africa . It was the South African Minister of Health himself, Zweli Mkwize, who announced it at a press conference, adding that 181 of them had lost their lives.

Britain has secured access to 90 million doses of potential coronavirus vaccines in deals with biotech firms BioNTech, Pfizer and Valneva. Britain would now have access to three different types of vaccines being developed. It had also launched a website for volunteers to sign up for vaccine studies.

UK agrees to buy potential coronavirus inoculations from BioNTech and Valneva. A laboratory expert at University of Oxford working to develop a vaccine for Britain has struck deals to secure a total of 90 m doses of potential Covid - 19 vaccines from companies based in Germany and France as the

Speaking to ITV’s Good Morning Britain on Friday, she said: “The issue is we don’t know which if any of these vaccines may work, because there have been no vaccines against any human coronavirus.

“So what we’re doing is we’ve chosen six of the most promising vaccines across four different vaccine types and we’re hoping that one of those will work.

“It would be a nice position if they all work, but that’s not likely. The reality is that most will fail and we want to be sure that if any one is shown to be effective and safe that we have rights to it.”

Ms Bingham said she was “reasonably confident” of a vaccine being found that will reduce the severity of coronavirus symptoms and reduce deaths.

The Government’s latest agreement follows on from 90 million doses in the pipeline under deals with an alliance between the pharmaceutical giants BioNtech and Pfizer, as well as the firm Valneva.

Is it ethical to infect volunteers with Covid-19 to test a vaccine?

  Is it ethical to infect volunteers with Covid-19 to test a vaccine? Seán McPartlin, from Rathoath, Co Meath in the Irish Republic is one of 1,100 people under the age of 30 who have signed up to test the effectiveness of a coronavirus vaccine.But that’s exactly what he might become. Astonishingly, the 22-year-old philosophy postgraduate student is one of a handful of men and women who could soon be willingly infected with the virus, as part of the groundbreaking vaccine trial being proposed by scientists at Oxford University.

A COVID ‑ 19 vaccine is a biotechnology intended to provide acquired immunity against coronavirus disease 2019 ( COVID ‑ 19 ). In July 2020, 218 vaccine candidates were in development, although no candidate has completed clinical trials to prove its safety and efficacy.

Scientists in the UK will begin trials of a potential Covid - 19 vaccine on humans Thursday, as the government warns it could have to rely on social distancing measures until next year assuming no vaccine or treatment is found before then.

Alok Sharma wearing a suit and tie: Alok Sharma (Aaron Chown/PA) © Provided by PA Media Alok Sharma (Aaron Chown/PA)

Some 100 million doses of vaccine could come from a vaccine being developed by Oxford University in partnership with AstraZeneca, while a deal has been struck for 60 million doses of GlaxoSmithKline (GSK) and Sanofi Pasteur’s potential Covid-19 vaccine.

The deals cover four different classes: adenoviral vaccines, mRNA vaccines, inactivated whole virus vaccines and protein adjuvant vaccines.

Business Secretary Alok Sharma said: “The Government’s strategy to build a portfolio of promising vaccine candidates will ensure we have the best chance possible of finding one that works.

“Today’s agreements will not only benefit people in the UK but will ensure fair and equitable access of a vaccine around the world, potentially protecting hundreds of millions of lives.

“While we are doing everything we can to ensure the British people get access to a successful vaccine as soon as possible, nobody is safe until we are all safe, so global cooperation is absolutely critical if we are to defeat this virus once and for all.”

WHO warns of a huge shortfall in funds to fight the coronavirus

 WHO warns of a huge shortfall in funds to fight the coronavirus © FABRICE COFFRINI / AFP WHO The World Health Organization warns about its insufficient funds to fight against the coronavirus. The director general of the World Health Organization (WHO) warned on Monday that there is a considerable gap between the funds needed to fight the COVID-19 pandemic and the sums pledged across the world.

The United States should have 100 million doses of one candidate coronavirus vaccine by the end of the year, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases and a member of the White House Coronavirus Task Force, said Tuesday.

Russia's homegrown Covid - 19 vaccine will create immunity for more than two years, according to the director of Moscow's Gamalei Institute of Epidemiology and Clinical trials of the vaccine are expected to be completed by the end of July. If successful, the drug will be officially registered, produced, and

The Janssen vaccine, which is being made available on a not-for-profit basis, is expected to begin the next phase of clinical trials later this year and will look at whether two doses can provide long-term protection from coronavirus.

Meanwhile, Novavax plans to make some of its vaccine at Fujifilm Diosynth Biotechnologies’s facilities in Billingham, Stockton-on-Tees in the north-east of England one it is available.

The Government said that if the Novavax and Janssen vaccines are proven safe and successful in clinical trials they could be delivered to the UK in mid-2021.

The vaccines would first be given to priority groups such as front-line health workers, those with serious diseases, the elderly and ethnic minorities.


Gallery: The COVID-19 vaccine race and the billions behind it (Lovemoney)

Since the genome sequence of the coronavirus was released back in January, more than 160 vaccines are currently in development, with 25 already being tested on humans, and world leaders have pledged a total of $8 billion (£6.5bn) to the cause. Developing a vaccination typically takes five to seven years but experts estimate that, thanks to previous research on different strands of coronavirus (eg outbreaks of SARS in 2002 and MERS in 2012) and the number of people working together, it’s possible that a year to 18 months could be a realistic timeline, although some institutions might get there even quicker. Click or scroll through what leading companies are doing in the race to find a COVID-19 vaccine. All dollar amounts in US dollars.

EU buys 300 million corona vaccinations at AstraZeneca - share falls anyway .
The European Union has secured hundreds of millions of doses of a possible vaccine against the coronavirus. © Provided by Finanz.net YASUYOSHI CHIBA / AFP / Getty Images According to its own information, the EU Commission concluded a first corresponding framework agreement with the pharmaceutical company AstraZeneca , as the authority announced on Friday in Brussels. This involves the purchase of 300 million cans with an option for a further 100 million.

—   Share news in the SOC. Networks
usr: 0
This is interesting!